Pathway-based signatures predict patient outcome, chemotherapy benefit and...
Introduction Invasive Lobular Carcinoma (ILC) is the second most commonly occurring histological subtype of breast cancers with up to 15% diagnosed. E-cadherin loss has been observed in >85% of ILCs and may be the cause...